# Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

> **NCT00427713** · PHASE3 · COMPLETED · sponsor: **Cancer Research UK** · enrollment: 800 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** standard follow-up care

## Key facts

- **NCT ID:** NCT00427713
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427713, "Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00427713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*